Ptc Therapeutics, Inc. (NASDAQ:PTCT) has 337 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 5,648,258 | 79.21% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 514,204 | 6.20% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -92,091 | -7.54% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 337,314 | 71.20% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -429,017 | -30.47% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 685,000 | 0.00% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 1,077,776 | 28.56% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 512,449 | 113.32% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -186,465 | -45.85% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,071,343 | 34.18% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -22,012 | -3.05% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -154,243 | -86.41% | $0.00 |
| Toronto Dominion Bank | 31 Dec, 2025 | 0 | 891,690 | 27.47% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 465,948 | 441.22% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | -1,051,239 | -21.37% | $0.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 0 | -8,464 | -1.93% | $0.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 0 | -475,403 | -14.51% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 65,184 | 3.34% | $0.00 |
| Russell Investments Group, Ltd. | 31 Dec, 2025 | 0 | 23,255 | 9.40% | $0.00 |